Drug Industry Urges Senate To Embrace Expedited Pathway For Breakthrough Therapies

March 2, 2015 at 4:35 PM
Two key drug industry groups are urging the Senate health panel to embrace an expedited approval pathway for breakthrough therapies as part of its recently unveiled initiative “Innovation for Healthier Americans” -- which parallels the House's 21st Century Cures efforts -- as well as weighing in on issues such as using real-world evidence to determine therapeutic benefits. But a key patient safety advocate is telling the committee that such a plan would impose unnecessary burdens on patients and physicians, who...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.